Post-approval studies (Phase 4)Study completedNCT05491356
What this trial is testing
Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas
Who this might be right for
Hematoma, SubduralFibrinolytic; Hemorrhage
Hamilton Health Sciences Corporation 40